Tri-Locum-Partners-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
22
Total Value
194900511
Accession Number
0001826434-25-000004
Form Type
13F-HR
Manager Name
Tri-Locum-Partners-Lp
Data Enrichment
100% identified
22 identified0 unidentified

Holdings

22 positions • $194.9M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
Cigna Group
Shares:73.9K
Value:$24.3M
% of Portfolio:12.5% ($24.3M/$194.9M)
MCKESSON CORP
Shares:26.9K
Value:$18.1M
% of Portfolio:9.3% ($18.1M/$194.9M)
SOLENO THERAPEUTICS INC
Shares:234.9K
Value:$16.8M
% of Portfolio:8.6% ($16.8M/$194.9M)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Shares:1.1M
Value:$16.3M
% of Portfolio:8.4% ($16.3M/$194.9M)
Inspire Medical Systems, Inc.
Shares:78.8K
Value:$12.6M
% of Portfolio:6.4% ($12.6M/$194.9M)
MADRIGAL PHARMACEUTICALS, INC.
Shares:37.9K
Value:$12.5M
% of Portfolio:6.4% ($12.5M/$194.9M)
Axsome Therapeutics, Inc.
Shares:101.2K
Value:$11.8M
% of Portfolio:6.1% ($11.8M/$194.9M)
ARGENX SE
Shares:17.8K
Value:$10.6M
% of Portfolio:5.4% ($10.6M/$194.9M)
GILEAD SCIENCES, INC.
Shares:89.5K
Value:$10.0M
% of Portfolio:5.1% ($10.0M/$194.9M)
ILLUMINA, INC.
Shares:120.7K
Value:$9.6M
% of Portfolio:4.9% ($9.6M/$194.9M)
INSMED Inc
Shares:101.9K
Value:$7.8M
% of Portfolio:4.0% ($7.8M/$194.9M)
Nuvalent, Inc.
Shares:95.8K
Value:$6.8M
% of Portfolio:3.5% ($6.8M/$194.9M)
Merus N.V.
Shares:156.9K
Value:$6.6M
% of Portfolio:3.4% ($6.6M/$194.9M)
GeneDx Holdings Corp.
Shares:58.1K
Value:$5.1M
% of Portfolio:2.6% ($5.1M/$194.9M)
Ascendis Pharma A/S
Shares:32.3K
Value:$5.0M
% of Portfolio:2.6% ($5.0M/$194.9M)
Blueprint Medicines Corp
Shares:50.0K
Value:$4.4M
% of Portfolio:2.3% ($4.4M/$194.9M)
Evolus, Inc.
Shares:321.8K
Value:$3.9M
% of Portfolio:2.0% ($3.9M/$194.9M)
Vera Therapeutics, Inc.
Shares:150.2K
Value:$3.6M
% of Portfolio:1.9% ($3.6M/$194.9M)
Stevanato Group S.p.A.
Shares:175.7K
Value:$3.6M
% of Portfolio:1.8% ($3.6M/$194.9M)
Praxis Precision Medicines, Inc.
Shares:83.7K
Value:$3.2M
% of Portfolio:1.6% ($3.2M/$194.9M)